Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes — nausea and vomiting are among the most commonly reported side effects of Mounjaro (tirzepatide), and for most people they are predictable, manageable, and tend to settle as the body adjusts. That said, feeling sick is not universal, and the severity varies considerably from person to person. Whether nausea is worth pushing through, or a signal that something needs to change, is the real decision this page helps you think through. Mounjaro is a prescription-only medicine; a clinician assesses whether it's right for you and guides any dose adjustments. The NHS tirzepatide medicines page lists nausea among the most common reported effects, which should reassure you that you're not alone if this has caught you off guard.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) that are involved in appetite signalling and blood-sugar regulation. One of its most clinically useful effects is slowing gastric emptying: food stays in the stomach longer, so you feel full sooner and for longer. That same mechanism is also what makes some people feel queasy, particularly in the first days after a new dose.
Your digestive system needs time to recalibrate. Eating a large meal, eating quickly, or lying down shortly after eating can tip an already-slower stomach into discomfort. Rich, fatty or spicy foods are frequent triggers. Some people also notice nausea if they inject in the evening and eat a heavier dinner than usual, keeping a pen in the fridge door and choosing a consistent injection day can help build a routine that reduces surprise flare-ups.
Vomiting specifically is less common than nausea, but it does happen. If you want a fuller picture of that particular experience, our page on vomiting on Mounjaro covers it in more detail. The short answer: occasional vomiting in the early weeks is recorded in clinical data; persistent or forceful vomiting is not something to sit with.
Fatigue sometimes compounds the sick feeling, and understanding whether feeling sick on Mounjaro is expected for your situation can help you tell the difference between typical adjustment and something worth flagging. You can read more about tiredness during Mounjaro treatment separately.
The distinction worth making is between nausea that is unpleasant but temporary and nausea that either doesn't settle or arrives alongside other warning signs.
Expected pattern: nausea and occasional vomiting are most common in the first week or two after starting 2.5 mg, or in the days after a dose step up. They tend to ease by the second week at that dose. By the time most people reach a higher maintenance dose, they have already experienced the worst of the GI adjustment and adapted.
When to seek medical help promptly: severe, persistent abdominal pain that radiates toward the back (with or without vomiting) needs urgent assessment, not a wait-and-see approach. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; that symptom pattern is the one to act on. Equally, vomiting so persistent that you cannot keep fluids down risks dehydration, which itself can affect the kidneys.
Signs of an allergic reaction (swelling of the face, lips or throat, difficulty breathing) need emergency care immediately. Yellow Card lets you report suspected side effects at yellowcard.mhra.gov.uk, and doing so contributes to the UK's ongoing safety monitoring for newer medicines like this one.
A broader overview of Mounjaro side effects covers the full range beyond GI symptoms if you're weighing up the wider picture.
These are the things most likely to make a real difference, drawn from what prescribers see regularly:
Eat smaller amounts at each meal. The stomach is emptying more slowly than it used to, a portion that felt normal before treatment may now feel like too much. Smaller, more frequent meals can side-step the discomfort entirely. Eat slowly and stop at the first real sense of fullness.
Avoid triggers. Fatty, heavily spiced or very sweet foods appear in most people's lists of things that made nausea worse. Fizzy drinks can compound bloating. Plain, mild food in the early weeks is not punishment, it's practical.
Stay hydrated with small sips rather than large glasses of water. Cold water sometimes helps; very hot drinks right after eating less so.
Timing the injection thoughtfully can help too. Some people find injecting on a day when they have lighter meals planned, or in the evening before a rest day, gives the body a gentler start. There is no single right answer; your prescriber can advise based on your routine.
If nausea is seriously affecting your quality of life or your ability to eat and drink, that is worth raising, not assuming you simply have to endure it. Dose timing, dose level and additional clinical support are all options a prescriber can explore with you.
Most people who experience nausea in the first fortnight on Mounjaro do not need to stop. They need to know it's expected, understand what makes it worse, and have a practical toolkit for managing it. That's the situation for the majority.
A smaller group find the nausea at a particular dose is genuinely debilitating, disrupting work, sleep or daily life in a sustained way. That's different, and it's worth talking to a prescriber about whether the dose needs to be held steady for longer before increasing, or whether something else is contributing. Pressing on through distressing symptoms without clinical input isn't necessary when support is available.
If you're considering Mounjaro and want to understand whether it's suitable for you, or you're already on treatment and the side effects aren't settling, speaking to our prescribers is the right next step. A named clinician, not software, will review your situation directly. You can also read more about how Mounjaro works and what the full treatment journey looks like. For questions about the cost of treatment, our Mounjaro price comparison page gives an honest breakdown of what private treatment involves.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.